BioNTech SE
BNTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001776985
In the last 90 days, BioNTech SE insiders filed 0 open-market purchases and 9 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $4.36B in total; ARK Invest is the only superinvestor holding it.
Superinvestors holding BNTX, Q2 2026
1 superinvestor reports holding BioNTech SE on Form 13F, worth $12.4M in total. Weight is BioNTech SE's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| ARK InvestCathie Wood | 0.1% | 133,333 | $12.4M | Added+4.3% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of BNTX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- ARK Invest (+4.3%)
Q1 2026
1 superinvestor holding at quarter end
- New
- ARK Invest
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q1 2025
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−6.5%)
Q4 2024
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+1,932.3%)
Q3 2024
1 superinvestor holding at quarter end
Q2 2023
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office
Q1 2023
1 superinvestor holding at quarter end
- New
- Duquesne Family Office
- Sold out
- Coatue Management
Q4 2022
1 superinvestor holding at quarter end
- Added
- Coatue Management (+46.6%)
Q1 2022
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−60.1%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- Coatue Management (+2.3%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- Coatue Management (−16.4%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- Coatue Management (+261.7%)